Its overdependence on vaccines leaves the country vulnerable to bioterrorism.

The trial did not find remdesivir is deadly, and trials in COVID patients have found adverse effects are generally mild and rare. AAP FACTCHECK - Antiviral drug remdesivir was not found to be "toxic" ...

Federal officials cited the end of the Covid-19 pandemic in halting the research. But much of the work was focused on ...

Studies on COVID, climate change and South Africa are on the latest list of terminated grants by the U.S. National Institutes ...

The Trump administration has cut funding for vaccine research since COVID-19 is not a pandemic but coronaviruses and ...

Clinical trials moved quickly, and by the end of the year we had the very first oral COVID ... coronavirus antiviral. It also slows the body metabolizing a whole assortment of drugs, from opioids ...

COVID, vaccine development, gender and sexual health are among the topics of research affected by canceled NIH grants in ...

A two-sentence paragraph in a new guidance document to National Institutes of Health grant managers brings a five-year surge ...

The Office for Long COVID Research and Practice was instrumental in coordinating the U.S. government’s initiatives to treat, ...

Preclinical and Phase 1 data suggest that ratutrelvir can be used without ritonavir and may reduce the likelihood of COVID rebound and the risk ...

Long COVID is arguably the most significant hangover from the pandemic. Here's what has been learned, and what remains ...

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses ...